Navigation Links
Predictability: The brass ring for synthetic biology
Date:3/14/2013

Predictability is often used synonymously with "boring," as in that story or that outcome was soooo predictable. For practioners of synthetic biology seeking to engineer valuable new microbes, however, predictability is the brass ring that must be captured. Researchers with the multi-institutional partnership known as BIOFAB have become the first to grab at least a portion of this ring by unveiling a package of public domain DNA sequences and statistical models that greatly increase the reliability and precision by which biological systems can be engineered.

The DNA sequences produced by BIOFAB provide precise control of gene expression in Escherichia coli, the rod-shaped bacterium that is one of the principal model organisms for genetic engineering. While these DNA sequences serve as standardized parts specific to E. coli, they also provide a set of rules for how the sequences fit together that should apply to other microbes as well. Controlling the expression of genes is essential for engineering a microbe to produce a specific product or carry out a specific function.

As BIOFAB co-director Adam Arkin, a computational biologist and director of Berkeley Lab's Physical Biosciences Division, has noted, "Fulfilling the great promise of synthetic biology hinges on making the design and construction of biological systems as predictable as the assembly of computer hardware."

Yet even with a microbe as well-characterized and understood as E. coli, the introduction of new genes has in the past been met with as much failure as success.

"You would think after a generation of genetic engineering, expressing genes with precision in an organism as well utilized as E. coli would be pretty straightforward but it's not," says BIOFAB's other co-director Drew Endy, a synthetic biologist at Stanford University.

Arkin and Endy are the corresponding authors of a pair of research papers published simultaneously in the journal Nature Methods, and a third to be published in Nucleic Acids Research, that collectively describe this major BIOFAB breakthrough.

BIOFAB's success is based on two major achievements - the design of independent DNA promoter and ribosome binding site sequences for specific E. coli genes, and the development of mathematical models that provide rules for engineering gene expression that should be applicable to nearly all organisms. This work establishes a much-needed technological foundation for the field of synthetic biology, which in turn should facilitate more precise and predictable genetic engineering in the future.


'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Related biology news :

1. Synthetic molecule first electricity-making catalyst to use iron to split hydrogen gas
2. Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
3. Developing microbial cell factories by employing synthetic small regulatory RNAs
4. Oscillating gel gives synthetic materials the ability to speak
5. Synthetic and biological nanoparticles combined to produce new metamaterials
6. New report finds increase in media coverage of synthetic biology
7. Synthetic fuel could eliminate US need for crude oil
8. Microchoreography: Researchers use synthetic molecule to guide cellular dance
9. Nottingham part of £20m investment for UK synthetic biology
10. Synthetic biofilter wins through to the top Sweet 16 in Boston
11. Collagen-seeking synthetic protein could lead doctors to tumor locations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Predictability: The brass ring for synthetic biology
(Date:2/22/2017)... 2017 With the biometrics market to ... four technologies that innovative and agile startups must ... in the changing competitive landscape: multifactor authentication (MFA), ... "Companies can no longer afford to ... Dimitrios Pavlakis , Industry Analyst at ABI ...
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/9/2017)... , Feb. 9, 2017 The biomass ... analysis of the biomass boiler market globally in terms ... of biomass boilers. The market for biomass boilers has ... type, end-user, application, and country/region. The market based on ... & forest residues, biogas & energy crops, urban residues, ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... Md. , March 27, 2017  The ... billion for 2016, according to a new report ... medical lab testing is performed to evaluate disease ... individual therapy, among other reasons.  The healthcare market ... Market , provides an overview of the ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... method to engineer scalable and customizable vascular grafts in JoVE’s Video Journal, the ... lead to new and improved ways of treating coronary artery disease (CAD). Lam ...
(Date:3/24/2017)... March 24, 2017 MiMedx Group, Inc. (NASDAQ: ... human placental tissue allografts and patent-protected processes to develop ... of healthcare, announced today  that it will present at ... , NY.  Parker H. "Pete" Petit, Chairman and ... Christopher M. Cashman , EVP and Chief Commercialization ...
(Date:3/24/2017)... 2017 On Thursday, March 23, ... 5,817.69, down 0.07%; the Dow Jones Industrial Average edged ... 500 closed at 2,345.96, marginally dropping 0.11%. US markets ... green, 4 sectors finished in red, and 1 sector ... initiated reports coverage on the following Biotechnology equities: BioDelivery ...
Breaking Biology Technology: